Mr. Bad Karma Kyle..
Pay attention to the link you just posted... here is a quote from the article..
Nor is synthetic biology the only promising area of scientific development. This week, Canopy Growth, a large Canadian marijuana company, said it would acquire cannabis and hemp-related technologies developed by the Colorado start-up Ebbu, including a way to greatly reduce the cost of producing CBD from hemp. If the science reaches designated milestones, the deal could be worth more than $300m. (Canada has just become the largest country to legalize recreational cannabis.)
With certain products, first to market, often wins the race. In addition the attractive feature of CVSI CBD products is the toxicology study already done. Who determines what the extraction process is? Who or what determines quality of the CBD produced? Not to mention the labeling being required by most states now for the sale of CBD in any form
The whole article is speculative at best.
There are cheaper options for consumers in all walks of life.
There are cheaper beers to buy and cheaper vodka brands to buy...
Big difference between Busch beer, and Sam Adams.....big difference between rail vodka and Belvedere.
Ebbu is some start up company that may or may not be able to achieve the science that they speak of.
You are talking years and years of R and D before anything could possibly happen...
CVSI doesn't need to be the only one in the space to be successful buddy. How many beer makers are there in the world?
Not worried about the up listing my friend. If the filing would have been rejected we would have known by now. I suspect they are working out details on Market Makers and other guidelines as this is the first US company in this space filing for NASDAQ..
You certainly like bad mouthing the company....seems to me you have too much time on your hands..
AI
Market Data 
Markets 
